close

Enter

Log in using OpenID

Nasal Polyps Treatment Market Study A Variety of Different Things

embed
Key players are constantly focused on developing novel approaches for treatment of nasal polyps, which is expected to impel the global nasal polyps’s treatment market growth.
Nasal Polyps Treatment Market Size, Share,
Trend, Outlook, Future Growth Analysis
And Synthesis 2019 - 2027
Nasal polyps are benign growths occurring inside the paranasal sinuses and in the lining of the nose.
Generally, it is characterized as a teardrop shaped and yellowish brown or pink in color. The size of the
polyps may vary and can be clustered or may grow alone. These can cause severe infections and
breathing difficulties, causing sleep apnea in some cases. The cause of nasal polyps can be due to
asthma, allergic infections, sinus infections, cystic fibrosis, etc. There are no particular symptoms that
develop but an inflammation in the lining of the nose can occur.
To Access the Free Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/2775
Global Nasal Polyps Treatment Market Drivers
Key players are constantly focused on developing novel approaches for treatment of nasal polyps, which
is expected to impel the global nasal polyps’s treatment market growth. For instance, in April 2018,
Intersect ENT Inc. launched a product, SINUVA. It is a sinus implant and used for treating nasal polyps.
It is a new way of treatment in patients with the past sinus surgeries. This implant contains 1.35 mg
mometasone furoate which is delivered, directly to the polyps. It is implanted for a definite period of
time (90 days).
Furthermore, in June 2019, Novartis AG revealed the phase III clinical trial study of Xolair,
Omalizumab. It is a monoclonal antibody used for treating nasal polyps. It tends to target and block the
immunoglobulin E. It was observed that the medication was generally well-tolerated in patients. Hence,
such developments of treatment for nasal polyps are expected to fuel the global nasal polyps treatment
market growth.
Increasing approvals from regulatory bodies related to nasal polyps treatment is expected to drive the
global nasal polyps treatment market growth. For instance, in June 2019, Dupixent received an approval
from the U.S. Food & Drug Administration (FDA) for treating with nasal polyps. It was manufactured
by Sanofi in partnership with Regeneron Pharmaceuticals Inc. It is the first treatment that got approved
for chronic rhinosinusitis with nasal polyps. It is used when the oral steroids are unable to control the
inflammation and to avoid the surgical method. Hence, such approvals are expected to impact positively
on the global nasal polyps treatment market growth.
Global Nasal Polyps Treatment Market Regional Analysis
North America is expected to hold a dominant position in the global nasal polyps treatment market.
Factors such as higher prevalence of asthma is expected to be a major contributor in the North
America’s nasal polyps treatment market growth. Nasal polyps are triggered due to asthma and also at
the same time nasal polyps can cause asthma. For instance, according to American Academy of Allergy,
Asthma & Immunology 2017, published data, around 28% to 40% patients with nasal polyps are
diagnosed with asthma. According to the same source, around 19% to 39% patients get nasal polyps who
are already suffering from asthma. Such increasing prevalence may increase the demand for treatment of
nasal polyps thereby expected to propel the global nasal polyps treatment market growth.
Report includes chapters which deeply display the following deliverable about industry :
• Nasal Polyps Treatment Market Research Objective and Assumption
• Nasal Polyps Treatment Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Nasal Polyps Treatment Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Nasal Polyps Treatment Market, By Regions
• Nasal Polyps Treatment Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Nasal Polyps Treatment Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Nasal Polyps Treatment Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Nasal Polyps Treatment Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Global Nasal Polyps Treatment Market Key Players
Some of the major players operating in the global nasal polyps treatment market include, Intersect ENT
Inc., GlaxoSmithKline Plc, Merck Sharp and Dohme Corp, Teva Branded Pharmaceutical Products R and
D Inc., Norton Waterford Ltd, Sanofi, Regeneron Pharmaceuticals Inc., Fougera Pharmaceuticals Inc.,
Glenmark, and Taro Pharmaceuticals Industries Ltd.
Global Nasal Polyps Treatment Market Taxonomy
By Drug
•
Fluticasone
•
Mometasone
•
Fluticasone
•
Beclomethasone
•
Prednisone
•
Others
By Route of Administration
•
Oral
•
Nasal
•
Injectable
Get Full Access of This Business Report: https://www.coherentmarketinsights.com/ongoinginsight/nasal-polyps-treatment-market-2775
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Poul Master
Poul Master247   documents Email
Document
Category
Health and Medicine
Views
3
File Size
120 KB
Tags
polyps, Nasal Polyps Treatment Market
1/--pages
Report inappropriate content